These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 6941455

  • 1. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Olsson-Liljequist B, Nord CE.
    Scand J Infect Dis Suppl; 1981; 26():42-5. PubMed ID: 6941455
    [Abstract] [Full Text] [Related]

  • 2. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A, Durieux R.
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam].
    Werner H, Kuchenbecker K, Hammann R.
    Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6681175
    [Abstract] [Full Text] [Related]

  • 4. [Anaerobic effect of tinidazol compared with metronidazol, ornidazol, cefoxitin and lamoxactam].
    Werner H, Kuchenbecker K, Hammann R.
    Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6676177
    [Abstract] [Full Text] [Related]

  • 5. [Study of obligate anaerobic bacterial sensitivity to tinidazole and metronidazole (determination of minimal inhibiting concentration--MIC)].
    Kałowski M, Dybicki J, Kedzia A, Lukiański M.
    Wiad Lek; 1993 Mar; 46(5-6):211-5. PubMed ID: 8249400
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.
    Wust J.
    Antimicrob Agents Chemother; 1977 Apr; 11(4):631-7. PubMed ID: 856015
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC, Martínez-Brocal A, Miranda C, Rojo MD, García V, Domínguez MC, de la Rosa M.
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.
    Goldstein EJ, Sutter VL, Finegold SM.
    Antimicrob Agents Chemother; 1978 Oct; 14(4):609-13. PubMed ID: 718156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro.
    Jokipii L, Jokipii AM.
    J Antimicrob Chemother; 1977 Nov; 3(6):571-7. PubMed ID: 599119
    [No Abstract] [Full Text] [Related]

  • 16. Nitroimidazoles, Part XXIII--activity of satranidazole series against anaerobic infections.
    Nagarajan K, Gowrishankar R, Arya VP, George T, Nair MD, Shenoy SJ, Sudarsanam V.
    Indian J Exp Biol; 1992 Mar; 30(3):193-200. PubMed ID: 1512026
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system.
    Jokipii AM, Jokipii L.
    Scand J Infect Dis Suppl; 1981 Mar; 26():123-9. PubMed ID: 6941449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.